Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
BIOIMPACT CAPITAL LLC | 08-11-2023 | 06-30-2023 | 34 | 496,602,631 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
Cullinan Oncology, Inc. | Common | 1 | $82,295,364 | 7,648,268 | 0.02 | 0.02 | 0 | 0.00 | 06-30-2023 |
Iveric Bio Inc | Common | 2 | $47,784,803 | 1,214,662 | 0.01 | 0.01 | 168,971 | 16.16 | 06-30-2023 |
Chinook Therapeutics, Inc. | Common | 3 | $38,550,859 | 1,003,406 | 0.01 | 0.00 | 805,600 | 407.27 | 06-30-2023 |
Geron Corporation | Common | 4 | $29,504,041 | 9,191,290 | 0.01 | 0.00 | 789,725 | 9.40 | 06-30-2023 |